• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Mesa Laboratories Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    6/6/25 3:00:33 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials
    Get the next $MLAB alert in real time by email
    mlab20250603_8k.htm
    false 0000724004 0000724004 2025-06-03 2025-06-03
     


     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549   
     
    FORM 8-K
     
    CURRENT REPORT
     
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
     
    Date of Report (Date of earliest event reported): June 3, 2025
     
    MESA LABORATORIES, INC.
    (Exact name of registrant as specified in its charter)
     
    Colorado
    (State or other jurisdiction of
    incorporation)
    0-11740
    (Commission File Number)
    84-0872291
    (I.R.S. Employer
    Identification No.)
     
    12100 West Sixth Avenue,
    Lakewood, Colorado
    (Address of principal executive offices)
     
    80228
    (Zip Code)
     
    Registrant’s telephone number, including area code: 303-987-8000
     
    Not Applicable
    (Former name or former address, if changed since last report)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
     
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
     
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
     
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered under Section 12(b) of the Act:
     
    Title of each class
     
    Trading Symbol
     
    Name of each exchange on which
    registered
             
    Common Stock, no par value
     
    MLAB
     
    The Nasdaq Stock Market LLC
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
     
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
     


     
     

     
     
    Item 4.01.
    Changes in Registrant’s Certifying Accountant.
     
     
    On June 3, 2025, Mesa Laboratories, Inc., (the "Company") was notified that Moss Adams LLP ("Moss Adams"), the Company's independent registered public accounting firm, merged with Baker Tilly US, LLP effective on June 3, 2025. The combined audit practices operate as Baker Tilly US, LLP (“Baker Tilly”). In connection with the notification of the merger, Moss Adams has resigned as the auditors of the Company and the Audit Committee of the Company’s Board of Directors approved the appointment of Baker Tilly, as the successor to Moss Adams, as the Company’s independent registered public accounting firm.
     
    The audit report of Moss Adams on the Company’s consolidated financial statements as of March 31, 2025, and for the year then ended, and internal control over financial reporting as of March 31, 2025, did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles.
     
    During the year ended March 31, 2025, and the subsequent interim period through June 3, 2025, there were no (a) disagreements with Moss Adams on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to Moss Adams’ satisfaction, would have caused it to make reference to the subject matter of the disagreement in connection with its reports on the Company’s financial statements, or (b) reportable events requiring disclosure pursuant to Item 304(a)(1)(v) of Regulation S-K.
     
    During the year ended March 31, 2025, and the subsequent interim period through the date of this Current Report on Form 8-K, neither the Company, nor anyone on its behalf, consulted with Baker Tilly regarding: (i) either the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements; or (ii) any matter that was either the subject of a “disagreement,” as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions to that item, or a “reportable event,” as described in Item 304(a)(1)(v) of Regulation S-K.
     
    The Company provided Moss Adams with a copy of this Current Report on Form 8-K prior to its filing with the Securities and Exchange Commission (the “Commission”) and requested that Moss Adams furnish the Company with a letter addressed to the Commission stating whether it agrees with the above statements and, if it does not agree, the respects in which it does not agree. A copy of Moss Adams’ letter to the Commission, dated June 3, 2025, is filed as Exhibit 16.1 to this Form 8-K and is incorporated herein by reference.
     
    Item 9.01.
    Financial Statements and Exhibits.
     
    (d)  Exhibits.
     
    Exhibit No.
     
    Description
    16.1
     
    Letter from Moss Adams Dated June 5, 2025
    104   Cover Page Interactive Data File (imbedded within the Inline XBRL document)
     
     

     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
    DATE: June 6, 2025
     
    Mesa Laboratories, Inc.
       
    (Registrant)
         
         
     
    BY: 
    /s/ Gary M. Owens  
       
    Gary M. Owens
       
    President and Chief Executive Officer
     
     
     
    Get the next $MLAB alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MLAB

    DatePrice TargetRatingAnalyst
    8/7/2025$67.00Underweight → Equal Weight
    Wells Fargo
    8/28/2024$120.00Underweight
    Wells Fargo
    1/4/2024$100.00 → $125.00In-line → Outperform
    Evercore ISI
    More analyst ratings

    $MLAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mesa Laboratories upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Mesa Laboratories from Underweight to Equal Weight and set a new price target of $67.00

    8/7/25 7:05:04 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Wells Fargo initiated coverage on Mesa Laboratories with a new price target

    Wells Fargo initiated coverage of Mesa Laboratories with a rating of Underweight and set a new price target of $120.00

    8/28/24 7:48:06 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Laboratories upgraded by Evercore ISI with a new price target

    Evercore ISI upgraded Mesa Laboratories from In-line to Outperform and set a new price target of $125.00 from $100.00 previously

    1/4/24 8:29:10 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ladiwala Shiraz Shabanali converted options into 1,949 shares, increasing direct ownership by 63% to 5,023 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    8/18/25 2:37:17 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Director Sullivan John James converted options into 1,404 shares, increasing direct ownership by 5% to 27,282 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    8/18/25 2:20:16 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Director Hall Shannon converted options into 1,404 shares, increasing direct ownership by 50% to 4,189 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    8/18/25 2:02:38 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. Uber Technologies Inc. (NYSE:UBER) will replace Charter Communications Inc. (NASD: CHTR) in the S&P 100. Charter Communications will remain in the S&P 500.AppLovin Corp. (NASD: APP), Robinhood Markets Inc. (NASD: H

    9/5/25 6:34:00 PM ET
    $ACHC
    $APP
    $BGS
    Medical Specialities
    Health Care
    Computer Software: Programming Data Processing
    Technology

    Mesa Laboratories Executes Previously-Announced Strategic Financing Plan

    LAKEWOOD, Colo., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that it has executed on its previously-announced financial strategy, repaying $97.5 million aggregate principal of the Company's 1.375% Convertible Senior Notes due August 2025 (the "2025 Notes"). On August 12, 2025, the Company drew $97.0 million under its existing Amended and Restated Credit Agreement (the "Credit Agreement"), bringing the total outstanding balance to $108 million. The proceeds from the draw were used to settle the 2025 Notes that matured on August 15, 2025. "This transaction reflects the disciplined execution of a plan we commu

    8/18/25 2:01:56 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Labs Announces First Quarter Results

    LAKEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its first fiscal quarter ("1Q26") ended June 30, 2025 (amounts in thousands). First quarter FY26 compared to first quarter FY25: Revenues increased 2.4%Non-GAAP core organic revenues1 growth was 0.4% Operating income decreased 45.1% to $3,064 primarily due to the impacts of FX and non-cash stock-based compensation expenseNon-GAAP adjusted operating income ("AOI") excluding unusual items2 decreased 15.9% and was 21.7% as a percentage of revenues   

    8/5/25 8:00:08 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    SEC Filings

    View All

    Mesa Laboratories Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

    8/25/25 3:13:26 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Laboratories Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

    8/18/25 2:03:45 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form 10-Q filed by Mesa Laboratories Inc.

    10-Q - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

    8/5/25 8:01:12 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Financials

    Live finance-specific insights

    View All

    MESA LABS DECLARES QUARTERLY DIVIDEND

    LAKEWOOD, Colo., July 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, inc

    7/3/25 12:00:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    MESA LABS DECLARES QUARTERLY DIVIDEND

    LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase p

    4/7/25 3:00:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    MESA LABS DECLARES QUARTERLY DIVIDEND

    LAKEWOOD, Colo., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 17, 2025, to shareholders of record at the close of business on February 28, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increa

    1/6/25 3:00:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Leadership Updates

    Live Leadership Updates

    View All

    AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. Uber Technologies Inc. (NYSE:UBER) will replace Charter Communications Inc. (NASD: CHTR) in the S&P 100. Charter Communications will remain in the S&P 500.AppLovin Corp. (NASD: APP), Robinhood Markets Inc. (NASD: H

    9/5/25 6:34:00 PM ET
    $ACHC
    $APP
    $BGS
    Medical Specialities
    Health Care
    Computer Software: Programming Data Processing
    Technology

    Mesa Laboratories Appoints Mark Capone to its Board of Directors

    LAKEWOOD, Colo., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa", "we", "us", or "our"), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the appointment of Mark Capone to its Board of Directors (the "Board"), effective January 5, 2024. Dr. John Sullivan, Ph.D., Chairman of the Board of Directors, stated: "We are pleased to welcome Mark to Mesa's Board. Mark is an accomplished life sciences executive with significant leadership and acquisitions experience spanning biopharmaceuticals, life science tools, and clinical genomics. We believe Mark's insights will be pivotal to Mesa

    1/8/24 8:00:00 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director

    LAKEWOOD, Colo., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or the "Company") today announced that Shiraz Ladiwala has been appointed to serve as the Lead Independent Director of its Board of Directors ("Board"), effective November 3, 2022. Mr. Ladiwala assumes this newly re-created role as an expansion of his current responsibilities on the Board, on which he has served since October 2021. Mr. Ladiwala was selected for this important role due to the thoughtful leadership and contributions he has made to the Board as well as the exceptional breadth of his professional experience. Mr. Ladiwala said, "I am delighted to accept this leadership role on Mes

    11/4/22 3:49:04 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mesa Laboratories Inc.

    SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

    10/15/24 1:29:56 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

    SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

    2/13/24 5:09:39 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

    SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

    1/23/24 2:18:26 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials